Search
Home
News
Coins2Day 500
Coins2Day Global 500
Coins2Day 500 Europe
Coins2Day China 500
Coins2Day SEA 500
Great Place To Work
Tech
AI
Innovation
Cybersecurity
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Success
Future Of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Analytics
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Home
News
Coins2Day 500
Coins2Day 500
Coins2Day Global 500
Coins2Day 500 Europe
Coins2Day China 500
Coins2Day SEA 500
Great Place To Work
Tech
Tech
AI
Innovation
Cybersecurity
Finance
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Leadership
Success
Future Of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Rankings
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Asia
Europe
Analytics
Laura Lorenzetti
Stay informed with Laura Lorenzetti’s coverage and analysis for Coins2Day.
Page 40 of 73
Tech
Imprivata, bulking up in health-care data security, buys biometrics maker HT Systems
By
Blockchain Reporter
Features
Wal-Mart in China, and Microsoft techies — 5 things to know today
By
Research Team
Features
Baltimore riots, Google, and Twitter earnings — 5 things to know today
By
Staff Writer
Features
6 places where genetically engineered crops are banned
By
Senior Editor
Retail
Chipotle nixes genetically modified ingredients from its menu
By
Editorial Team
Features
Apple reports, and Deutche Bank cuts — 5 things to know today
By
Trading Desk
Features
Betting big on health
By
Staff Writer
Tech
Intel-Edico partnership aims to break a medical logjam
By
Contributing Writer
Features
We need more antibiotics
By
Contributing Writer
Features
Facebook reports, and Tesco’s historic loss — 5 things to know today
By
Financial Writer
Retail
The bird flu outbreak is bad for food companies, but it’s not a public health crisis — here’s why
By
Digital Assets Editor
Finance
Teva offers to buy rival Mylan for $40 billion to create generics giant
By
Senior Editor
Retail
Blue Bell Creameries pulls all its products over listeria risk
By
Digital Assets Editor
Features
EU goes after Gazprom, and Teva eyes Mylan — 5 things to know today
By
News Correspondent
Features
China adds more stimulus, and IBM reports — 5 things to know today
By
Market Analyst
![DNA Rx In 2003, a team of researchers working for the Department of Energy and the National Institutes of Health completed a 13-year long effort called the Human Genome Project. The goal of the project was, among other things, to identify and map every gene in human DNA. For a while, the scientific community has […]](https://fortune.com/img-assets/wp-content/uploads/2012/12/121221050822-128144954.jpg?w=1440&q=75)
